NOTE Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Headwinds Eagle Materials Q1 2026 Earnings EPS Surges 206 Above Estimates Shares Rally QRHC Q1 2026 Earnings EPS Misses Estimates by 27 as Stock Edges Up BNR Q3 2022 Earnings Narrower Loss Surpasses Estimates Stock Declines CIMP Q1 2026 Earnings EPS Surpasses Estimates as Company Demonstrates Resilient Performance ParkerHannifin PH Holds Steady Near 867 Amid Mixed Market Sentiment Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29 Space Asset Acquisition Corp Warrants SAAQW Surge 106 as Momentum Builds Toward Key Resistance Design Therapeutics DSGN Edges Higher as Support Holds Above 1060 Benitec Biopharma BNTC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline